New chemo drug aims to keep lung cancer away after surgery
Disease control
Recruiting now
This study tests a new chemotherapy drug called SMS001 in 42 people with non-small cell lung cancer (stages Ib to IIIa). The goal is to find a safe dose and see if it can prevent the cancer from returning after surgery. Participants will receive SMS001 as an extra treatment after…
Phase: PHASE2 • Sponsor: ToLymph Inc. • Aim: Disease control
Last updated May 11, 2026 20:38 UTC